Literature DB >> 17855153

Epidermal growth factor receptor degradation: an alternative view of oncogenic pathways.

Andreas Kirisits1, Dietmar Pils, Michael Krainer.   

Abstract

Positive regulation of epidermal growth factor receptor signalling is related to many human malignancies. Besides overexpression and gain of function mutations, the escape from negative regulation through an increase in epidermal growth factor receptor stability has evolved as yet another key factor contributing to enhanced receptor activity. Intensive research over the past years has provided considerable evidence concerning the molecular mechanisms which provide epidermal growth factor receptor degradation. c-Cbl mediated ubiquitination, endocytosis via clathrin-coated pits, endosomal sorting and lysosomal degradation have become well-investigated cornerstones. Recent findings on the interdependency of the endosomal sorting complexes required for transport in multivesicular body sorting, stress the topicality of receptor tyrosine kinase downregulation. Here, we review the degradation pathway of the epidermal growth factor receptor, following the receptor from ligand binding to the lysosome and illustrating different modes of oncogenic deregulation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17855153     DOI: 10.1016/j.biocel.2007.07.012

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  24 in total

Review 1.  Degradation of activated protein kinases by ubiquitination.

Authors:  Zhimin Lu; Tony Hunter
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

2.  Oncogenic tyrosine kinases target Dok-1 for ubiquitin-mediated proteasomal degradation to promote cell transformation.

Authors:  Justyna A Janas; Linda Van Aelst
Journal:  Mol Cell Biol       Date:  2011-05-02       Impact factor: 4.272

3.  Suppression of EGFR endocytosis by dynamin depletion reveals that EGFR signaling occurs primarily at the plasma membrane.

Authors:  Leiliane P Sousa; Irit Lax; Hongying Shen; Shawn M Ferguson; Pietro De Camilli; Joseph Schlessinger
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-27       Impact factor: 11.205

4.  Molecular pathways: turning proteasomal protein degradation into a unique treatment approach.

Authors:  Sebastian Stintzing; Heinz-Josef Lenz
Journal:  Clin Cancer Res       Date:  2014-04-22       Impact factor: 12.531

5.  Andrographolide regulates epidermal growth factor receptor and transferrin receptor trafficking in epidermoid carcinoma (A-431) cells.

Authors:  Y Tan; K H Chiow; D Huang; S H Wong
Journal:  Br J Pharmacol       Date:  2010-02-19       Impact factor: 8.739

6.  Polyclonal immune responses to antigens associated with cancer signaling pathways and new strategies to enhance cancer vaccines.

Authors:  Timothy M Clay; Takuya Osada; Zachary C Hartman; Amy Hobeika; Gayathri Devi; Michael A Morse; H Kim Lyerly
Journal:  Immunol Res       Date:  2011-04       Impact factor: 2.829

7.  c-Src associates with ErbB2 through an interaction between catalytic domains and confers enhanced transforming potential.

Authors:  Richard Marcotte; Lixin Zhou; Harold Kim; Calvin D Roskelly; William J Muller
Journal:  Mol Cell Biol       Date:  2009-08-24       Impact factor: 4.272

8.  Synergism from combined immunologic and pharmacologic inhibition of HER2 in vivo.

Authors:  Michael A Morse; Junping Wei; Zachary Hartman; Wenle Xia; Xiu-Rong Ren; Gangjun Lei; William T Barry; Takuya Osada; Amy C Hobeika; Sharon Peplinski; Haixiang Jiang; Gayathri R Devi; Wei Chen; Neil Spector; Andrea Amalfitano; H Kim Lyerly; Timothy M Clay
Journal:  Int J Cancer       Date:  2010-06-15       Impact factor: 7.396

9.  LRIG1 negatively regulates the oncogenic EGF receptor mutant EGFRvIII.

Authors:  M A Stutz; D L Shattuck; M B Laederich; K L Carraway; C Sweeney
Journal:  Oncogene       Date:  2008-06-09       Impact factor: 9.867

10.  Destabilization of the epidermal growth factor receptor (EGFR) by a peptide that inhibits EGFR binding to heat shock protein 90 and receptor dimerization.

Authors:  Aarif Ahsan; Dipankar Ray; Susmita G Ramanand; Ashok Hegde; Christopher Whitehead; Alnawaz Rehemtulla; Yoshihiro Morishima; William B Pratt; Yoichi Osawa; Theodore S Lawrence; Mukesh K Nyati
Journal:  J Biol Chem       Date:  2013-07-29       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.